Publication number: 20250197388
Abstract: The disclosure provides pharmaceutical compositions comprising a therapeutically effective amount of compound (A), compound (B), compound (C), compound (D), compound (E), compound (F), compound (G), compound (H), compound (J), compound (K), compound (L), compound (M), compound (N), compound (O), compound (P), or compound (Q) or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient: Also provided are dosage units comprising one or more of compound (A), compound (B), compound (C), compound (D), compound (E), compound (F), compound (G), compound (H), compound (J), compound (K), compound (L), compound (M), compound (N), compound (O), compound (P), or compound (Q) or the pharmaceutical compositions described herein, methods of treating an inflammatory bowel disease in a subject in need thereof, or methods of modulating an inflammatory bowel disease marker in a subject in need thereof.
Type:
Application
Filed:
March 29, 2023
Publication date:
June 19, 2025
Inventors:
Pranatchareeya CHANKHAMJON, Kevin D. KREUTTER, Jason PARK, Zachary Lawrence REITZ, Francesco G. SALITURO, Sabrina Yusang YANG, Nir GRABIE, David Richard JACKSON, Hsin-yu LEE